TRDA · Entrada Therapeutics, Inc. · Congressional Trades
$5.17
-0.27 (-4.96%)
At close · Nov 12
Return incl. dividend (before tax)
Play latest call
Q1 2026 earnings call transcript
Going-concern doubt
— flagged Nov 5, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As a result of our recurring losses from operations and recurring negative cash flows from operations, there is substantial doubt about our ability to continue as a going concern.”View the 10-Q filed Nov 5, 2026
Market Cap
$202.41M
Shares
39.15M
Volume · Nov 12
808.67K
Avg daily vol (3M)
365.68K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Transactions in this listed security by members of the U.S. Congress, disclosed under the STOCK Act. Lawmakers must report trades within 45 days, so the filing date can lag the trade itself.
No Congressional Trades
No congressional trading data is available for this listed security yet.
Key facts
CIK
1689375
CUSIP
29384C108
13F (30d)
70 filings
57 filers
Visit website
Investor relations